Offer - Urjas Oil for just ₹ 1 X
D.D.Pramine 10 Mg Tablet is a prescription drug, available for use as Tablet. It is typically used for the treatment of Obsessive Compulsive Disorder.
Medical history of the patient along with age and gender determines the dosage of D.D.Pramine 10 Mg Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed D.D.Pramine 10 Mg Tablet side effects, there are can be others also. These have been listed below. These side effects of D.D.Pramine 10 Mg Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, D.D.Pramine 10 Mg Tablet's effect is Moderate during pregnancy and Severe for lactating mothers. Warnings related to D.D.Pramine 10 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
D.D.Pramine 10 Mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid D.D.Pramine 10 Mg Tablet in conditions like Heart Disease, Coronary Artery Disease (CAD), Suicidal Tendency. Some other conditions that can be affected by D.D.Pramine 10 Mg Tablet are listed in the contraindications section below.
Drug interactions for D.D.Pramine 10 Mg Tablet have been reported in the medical literature. A complete list of these interactions is given below.
In addition to these precautions, you may also note that D.D.Pramine 10 Mg Tablet is not safe while driving, and is is not addictive in nature.
D.D.Pramine 10 Mg Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of D.D.Pramine 10 Mg Tablet safe for pregnant women?
D D Pramine can have harmful effects in pregnant women. If you experience any discomfort after using D D Pramine, then discontinue the use and take your doctor's advice.
Is the use of D.D.Pramine 10 Mg Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking D D Pramine. It should only be taken after medical advice.
What is the effect of D.D.Pramine 10 Mg Tablet on the Kidneys?
D D Pramine is completely safe for kidneys.
What is the effect of D.D.Pramine 10 Mg Tablet on the Liver?
Side effects of D D Pramine rarely affect the liver.
What is the effect of D.D.Pramine 10 Mg Tablet on the Heart?
D D Pramine has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take D.D.Pramine 10 Mg Tablet unless your doctor advises you to do so -
Is this D.D.Pramine 10 Mg Tablet habit forming or addictive?
D.D.Pramine 10 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking D.D.Pramine 10 Mg Tablet as you may feel sleepy.
Is it safe?
Yes, but consume D.D.Pramine 10 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
Yes, D.D.Pramine 10 Mg Tablet is useful in treating mental disorders.
Interaction between Food and D.D.Pramine 10 Mg Tablet
You can take D.D.Pramine 10 Mg Tablet with food.
Interaction between Alcohol and D.D.Pramine 10 Mg Tablet
Consult your doctor before consuming alcohol while taking D.D.Pramine 10 Mg Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Anafranil® (clomipramine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 454, 456, 458, 464